Pfizer raises outlook on back of demand for non-Covid drugs
Vaccine maker posts 7% rise in revenue from medicines including blockbuster blood thinner
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.